A15903
LanthaScreen™ LanthaScreen™ TR-FRET Progesterone Receptor Coactivator Assay Kit
Manufacturer: LanthaScreen™
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | A15903-Each-of-1 | In Stock | ₹ 1,83,954.00 |
A15903 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 1,83,954.00
GST (18%): ₹ 33,111.72
Total Price: ₹ 2,17,065.72
Content And Storage
1 tube PR Ligand Binding Domain Recombinant Protein (store at -68 to -85°C)1 tube of Peptide (store at -5 to -30°C)2 bottles TR-FRET Buffer (store at -5 to -30°C)1 tube Tb-Anti-GST Ab (store at -5 to -30°C)1 tube of DTT (store at -5 to -30°C)
Product Line
LanthaScreen™
Type
Coactivator Assay Kit
For Use With (Application)
Co-Factor Interaction Assay, Nuclear Receptor Assay
Quantity
800 x 20 μL assays
Related Products
Description
- The LanthaScreen™ TR-FRET Progesterone Receptor Coactivator Assay Kit provides a sensitive and robust method for high-throughput screening of potential progesterone receptor (PR) ligands as agonists or antagonists of ligand-dependent coactivator recruitment
- The kit uses a PR ligand--binding domain (PR-LBD) tagged with glutathione-S-transferase (GST) (also available separately), a terbium (Tb)-labeled anti-GST antibody, and a fluorescein-labeled coactivator peptide in a homogenous mix-and-read assay format
- Agonist Mode - When using the LanthaScreen TR-FRET Progesterone Receptor Coactivator Assay in agonist mode (to identify agonist compounds), PR-LBD is added to ligand test compounds, followed by the addition of a mixture of fluorescein-labeled coactivator peptide and Tb-labeled anti-GST antibody
- After an incubation period at room temperature, the TR-FRET ratio of 520/495 nm is calculated and can be used to determine the EC50 from a dose response curve of the compound
- Based on the biology of the PR-coactivator peptide interaction, this ligand EC50 is a composite value representing the amount of ligand required to bind to receptor, effect a conformational change, and recruit coactivator peptide
- Antagonist Mode - When using the LanthaScreen™ TR-FRET Progesterone Receptor Coactivator Assay in antagonist mode (to identify antagonist compounds), PR-LBD is added to ligand test compounds followed by addition of a mixture of agonist, fluorescein-labeled coactivator peptide, and terbium-labeled anti-GST antibody
- The concentration of agonist used in this mode is the EC80 concentration as determined by first running the assay in agonist mode.
Compare Similar Items
Show Difference
Content And Storage: 1 tube PR Ligand Binding Domain Recombinant Protein (store at -68 to -85°C)1 tube of Peptide (store at -5 to -30°C)2 bottles TR-FRET Buffer (store at -5 to -30°C)1 tube Tb-Anti-GST Ab (store at -5 to -30°C)1 tube of DTT (store at -5 to -30°C)
Product Line: LanthaScreen™
Type: Coactivator Assay Kit
For Use With (Application): Co-Factor Interaction Assay, Nuclear Receptor Assay
Quantity: 800 x 20 μL assays
Content And Storage:
1 tube PR Ligand Binding Domain Recombinant Protein (store at -68 to -85°C)1 tube of Peptide (store at -5 to -30°C)2 bottles TR-FRET Buffer (store at -5 to -30°C)1 tube Tb-Anti-GST Ab (store at -5 to -30°C)1 tube of DTT (store at -5 to -30°C)
Product Line:
LanthaScreen™
Type:
Coactivator Assay Kit
For Use With (Application):
Co-Factor Interaction Assay, Nuclear Receptor Assay
Quantity:
800 x 20 μL assays
Content And Storage: __
Product Line: __
Type: __
For Use With (Application): __
Quantity: __
Content And Storage:
__
Product Line:
__
Type:
__
For Use With (Application):
__
Quantity:
__
Content And Storage: __
Product Line: __
Type: __
For Use With (Application): __
Quantity: __
Content And Storage:
__
Product Line:
__
Type:
__
For Use With (Application):
__
Quantity:
__
Content And Storage: __
Product Line: __
Type: __
For Use With (Application): __
Quantity: __
Content And Storage:
__
Product Line:
__
Type:
__
For Use With (Application):
__
Quantity:
__